Mario Clerici

Articles in Scholarly Journals [Incomplete List]

  1. Modulation of innate and adaptive immunity by lactoferrin in human immunodeficiency virus (HIV)-infected, antiretroviral therapy-naïve children
    International Journal of Antimicrobial Agents, vol. 29, no. 3, pp. 353–355, 2007
  2. Protease Inhibitor-Associated Increased Risk of Preterm Delivery Is an Immunological Complication of Therapy
    The Journal of Infectious Diseases, vol. 195, no. 6, pp. 914–916, 2007
  3. Apolipoprotein B mRNA-Editing Enzyme, Catalytic Polypeptide-Like 3G: A Possible Role in the Resistance to HIV of HIV-Exposed Seronegative Individuals
    The Journal of Infectious Diseases, vol. 195, no. 7, pp. 960–964, 2007
  4. Immune activation and normal levels of endogenous antivirals are seen in healthy adolescents born of HIV-infected mothers
    AIDS, vol. 21, no. 2, p. 245???248, 2007
  5. Disarming dendritic cells: a tumor strategy to escape from immune control?
    Expert Review of Clinical Immunology, vol. 3, no. 3, pp. 411–422, 2007
  6. An Immunological Comparison of Third Companion in Advanced Drug-Naive HIV-Infected Patients
    HIV Clinical Trials, vol. 7, no. 5, pp. 221–228, 2006
  7. Immunomodulants for the treatment of HIV infection: the search goes on
    Expert Opinion on Investigational Drugs, vol. 15, no. 3, pp. 197–200, 2006
  8. Thalidomide in the Treatment of Chronic Hepatitis C Unresponsive to Alfa-Interferon and Ribavirin
    The American Journal of Gastroenterology, vol. 101, no. 2, pp. 399–402, 2006
  9. Unusual presentation of acute cytomegalovirus disease during primary HIV-1 infection: antigen-specific T-cell response analyses and clinical outcome
    AIDS, vol. 20, no. 11, p. 1566???1567, 2006
  10. Comparative analysis of T-cell turnover and homeostatic parameters in HIV-infected patients with discordant immune-virological responses to HAART
    AIDS, vol. 20, no. 13, p. 1727???1736, 2006
  11. Unusual T-cell Repopulation after Autologous Stem Cell Transplantation for HIV-associated Lymphoma
    Transplantation, vol. 81, no. 12, pp. 1752–1753, 2006
  12. Dual Diagnosis—Policy and Practice in Italy
    American Journal on Addictions, vol. 15, no. 2, pp. 125–130, 2006
  13. Hiv-specific secretory IgA in breast milk of HIV-positive mothers is not associated with protection against HIV transmission among breast-fed infants
    The Journal of Pediatrics, vol. 149, no. 5, pp. 611–616, 2006
  14. Antiretroviral therapy-associated modulation of Th1 and Th2 immune responses in HIV-infected pregnant women
    Journal of Reproductive Immunology, vol. 70, no. 1-2, pp. 143–150, 2006
  15. Immunization with gp120-depleted whole killed HIV immunogen and a second-generation CpG DNA elicits strong HIV-specific responses in mice
    Vaccine, vol. 24, no. 9, pp. 1470–1477, 2006
  16. Low interleukin-10 production is associated with diabetes in HIV-infected patients undergoing antiviral therapy
    Medical Microbiology and Immunology, vol. 195, no. 3, pp. 125–132, 2006
  17. Decrease in pathology and progression of scrapie after immunisation with synthetic prion protein peptides in hamsters
    Vaccine, vol. 23, no. 22, pp. 2862–2868, 2005
  18. Preparing for phase II/III HIV vaccine trials in Africa
    Microbes and Infection, 2005
  19. Programmed cell death of myelin basic protein-specific T lymphocytes is reduced in patients with acute multiple sclerosis
    Journal of Neuroimmunology, vol. 166, no. 1-2, pp. 173–179, 2005
  20. Predictive value of anti-cell and anti-human immunodeficiency virus (HIV) humoral responses in HIV-1-exposed seronegative cohorts of European and Asian origin
    Journal of General Virology, vol. 86, no. 2, pp. 339–348, 2005
  21. Human ?? Defensin in HIV-Exposed But Uninfected Individuals
    JAIDS Journal of Acquired Immune Deficiency Syndromes, vol. 35, no. 5, pp. 455–463, 2004
  22. Interleukin-2 immunotherapy exerts a differential effect on CD4 and CD8 T cell dynamics
    AIDS, vol. 18, no. 2, pp. 211–216, 2004
  23. Granule-dependent mechanisms of lysis are defective in CD8 T cells of HIV-infected, antiretroviral therapy-treated individuals
    AIDS, vol. 18, no. 6, pp. 859–869, 2004
  24. Growth hormone in T-lymphocyte thymic and postthymic development: A study in HIV-infected children
    The Journal of Pediatrics, vol. 145, no. 4, pp. 542–548, 2004
  25. Interleukin-10 and interleukin-6 gene polymorphisms as risk factors for Alzheimer’s disease
    Neurobiology of Aging, vol. 25, no. 8, pp. 1009–1015, 2004
  26. Research on Psychoimmunology
    The World Journal of Biological Psychiatry, vol. 4, no. 3, pp. 119–123, 2003
  27. Assessment of immune reconstitution to Pneumocystis carinii in HIV-1 patients under different highly active antiretroviral therapy regimens
    Journal of Antimicrobial Chemotherapy, vol. 52, no. 2, pp. 276–281, 2003
  28. Distinct immune profiles characterize patients with diffuse or limited systemic sclerosis
    Clinical Immunology, vol. 108, no. 1, pp. 21–28, 2003
  29. Altered maturation of peripheral blood dendritic cells in patients with breast cancer
    British Journal of Cancer, vol. 89, no. 8, Article ID 6601243, 9 pages, 2003
  30. The Italian Association on Addiction Psychiatry (SIPDip), formerly The Italian Association on Abuse and Addictive Behaviours
    Addiction, vol. 98, no. 8, pp. 1039–1042, 2003
  31. Aids, vol. 17, no. 4, pp. 531–539, 2003
  32. AIDS, vol. 17, no. 10, pp. 1563–1565, 2003
  33. Productive Infection Maintains a Dynamic Steady State of Residual Viremia in Human Immunodeficiency Virus Type 1-Infected Persons Treated with Suppressive Antiretroviral Therapy for Five Years
    Journal of Virology, vol. 77, no. 20, pp. 11212–11219, 2003
  34. B7-H1 is up-regulated in HIV infection and is a novel surrogate marker of disease progression
    Blood, vol. 101, no. 7, pp. 2514–2520, 2003
  35. Functional repertoire of dendritic cells generated in granulocyte macrophage-colony stimulating factor and interferon- 
    Journal of Leukocyte Biology, vol. 75, no. 1, pp. 106–116, 2003
  36. Selective granulocyte/monocyte apheresis in the treatment of HIV-infected patients: short-term and long-term effects on immunological and virological parameters
    Perfusion, vol. 17, no. 2, pp. 47–51, 2002
  37. Immune Profiles of Patients with Chronic Idiopathic Urticaria
    International Archives of Allergy and Immunology, vol. 128, no. 1, pp. 59–66, 2002
  38. Hemodynamic and Autonomic Adjustments to Real Life Stress Conditions in Humans
    Hypertension, vol. 39, no. 1, pp. 184–188, 2002
  39. Modulation of Human Immunodeficiency Virus (HIV)-Specific Immune Response by Using Efavirenz, Nelfinavir, and Stavudine in a Rescue Therapy Regimen for HIV-Infected, Drug-Experienced Patients
    Clinical and Diagnostic Laboratory Immunology, vol. 9, no. 5, pp. 1114–1118, 2002
  40. Aids, vol. 16, no. 13, pp. 1731–1741, 2002
  41. Aids, vol. 16, no. 13, pp. 1767–1773, 2002
  42. Aids, vol. 16, no. 16, pp. 2219–2221, 2002
  43. Long-term pertussis-specific immune responses to a combined diphtheria, tetanus, tricomponent acellular pertussis and hepatitis B vaccine in pre-term infants
    Vaccine, vol. 20, no. 23-24, pp. 2928–2932, 2002
  44. Cytokine profiles in schizophrenic patients treated with risperidone A 3-month follow-up study
    Progress in Neuro-Psychopharmacology and Biological Psychiatry, vol. 26, no. 1, pp. 33–39, 2002
  45. Low-Dose Prolonged Intermittent Interleukin-2 Adjuvant Therapy: Results of a Randomized Trial among Human Immunodeficiency Virus–Positive Patients with Advanced Immune Impairment
    The Journal of Infectious Diseases, vol. 186, no. 5, pp. 606–616, 2002
  46. AIDS in Africa
    The Lancet, vol. 360, no. 9343, pp. 1422–1423, 2002
  47. AIDS in Africa
    The Lancet, vol. 360, no. 9343, pp. 1424–1424, 2002
  48. Serum Concentration of ?GT Is a Surrogate Marker of Hepatic TNF-a mRNA Expression in Chronic Hepatitis C
    Clinical Immunology, vol. 105, no. 3, pp. 279–285, 2002
  49. Immunovirological improvement in partially HAART responder HIV-infected patients by monocyte adsorption apheresis
    Journal of Clinical Apheresis, vol. 16, no. 1, pp. 35–36, 2001
  50. Reduced HIV-stimulated T-helper cell reactivity in cord blood with short-course antiretroviral treatment for prevention of maternal-infant transmission
    Clinical and Experimental Immunology, vol. 123, no. 3, pp. 443–450, 2001
  51. Functional HIV-1 specific IgA antibodies in HIV-1 exposed, persistently IgG seronegative female sex workers
    Immunology Letters, vol. 79, no. 1-2, pp. 29–36, 2001
  52. Single-cell analysis of cytokine production shows different immune profiles in multiple sclerosis patients with active or quiescent disease
    Journal of Neuroimmunology, vol. 121, no. 1-2, pp. 88–101, 2001
  53. T-helper cell responses to HIV envelope peptides in cord blood: protection against intrapartum and breast-feeding transmission
    AIDS, vol. 15, no. 1, pp. 1–9, 2001
  54. Mucosal IgA in exposed, uninfected subjects: evidence for a role in protection against HIV infection
    AIDS, vol. 15, no. 3, pp. 431–432, 2001
  55. Long-Term Pertussis-Specific Immunity after Primary Vaccination with a Combined Diphtheria, Tetanus, Tricomponent Acellular Pertussis, and Hepatitis B Vaccine in Comparison with That after Natural Infection
    Infection and Immunity, vol. 69, no. 7, pp. 4516–4520, 2001
  56. African Enigma: Key Player in Human Immunodeficiency Virus Pathogenesis in Developing Countries?
    Clinical and Diagnostic Laboratory Immunology, vol. 8, no. 5, pp. 864–866, 2001
  57. Different immunologic profiles characterize HIV infection in highly active antiretroviral therapy-treated and antiretroviral-na??ve patients with undetectable viraemia
    AIDS, vol. 14, no. 2, pp. 109–116, 2000
  58. Aids, vol. 14, no. 3, pp. 251–261, 2000
  59. Clinical and immunological benefit of adjuvant therapy with thalidomide in the treatment of tuberculosis disease
    AIDS, vol. 14, no. 12, pp. 1859–1861, 2000
  60. Mucosal and plasma IgA from HIV-exposed seronegative individuals neutralize a primary HIV-1 isolate
    AIDS, vol. 14, no. 13, pp. 1917–1920, 2000
  61. Immune activation in Africa is environmentally-driven and is associated with upregulation of CCR5
    AIDS, vol. 14, no. 14, pp. 2083–2092, 2000
  62. Transient Detection of Plasma HIV-1 RNA During Postexposure Prophylaxis
    Infection Control and Hospital Epidemiology, vol. 21, no. 8, pp. 529–531, 2000
  63. Effect of two different combinations of antiretrovirals (AZT+ddI and AZT+3TC) on cytokine production and apoptosis in asymptomatic HIV infection
    Antiviral Research, vol. 46, no. 3, pp. 171–179, 2000
  64. Tumor Necrosis Factor–a Increased Production during Thalidomide Treatment in Patients with Tuberculosis and Human Immunodeficiency Virus Coinfection
    The Journal of Infectious Diseases, vol. 182, no. 2, pp. 639–639, 2000
  65. Mucosal and Systemic Immune Activation Is Present in Human Immunodeficiency Virus–Exposed Seronegative Women
    The Journal of Infectious Diseases, vol. 182, no. 5, pp. 1365–1374, 2000
  66. In Vitro Immunomodulatory Properties of Tucaresol in HIV Infection
    Clinical Immunology, vol. 97, no. 3, pp. 211–220, 2000
  67. Altered Signaling Lymphocytic Activation Molecule (SLAM) Expression in HIV Infection and Redirection of HIV-Specific Responses via SLAM Triggering
    Clinical Immunology, vol. 92, no. 3, pp. 276–284, 1999
  68. Association of diabetes mellitus and chronic hepatitis C virus infection
    Hepatology, vol. 30, no. 2, pp. 584–584, 1999
  69. Clinical and immuno-virologic characterization of the efficacy of stavudine, lamivudine, and indinavir in human immunodeficiency virus infection?, ??, ?
    The Journal of Pediatrics, vol. 135, no. 6, pp. 675–682, 1999
  70. Human Immunodeficiency Virus (HIV)–Specific IgA and HIV Neutralizing Activity in the Serum of Exposed Seronegative Partners of HIV-Seropositive Persons
    The Journal of Infectious Diseases, vol. 180, no. 3, pp. 871–875, 1999
  71. The Effects of CD40 Ligation on Peripheral Blood Mononuclear Cell Interleukin-12 and Interleukin-15 Production and on Monocyte CD14 Surface Antigen Expression in Human Immunodeficiency Virus-Positive Patients
    Scandinavian Journal of Immunology, vol. 49, no. 3, pp. 286–292, 1999
  72. Effect of Zidovudine Postexposure Prophylaxis on the Development of HIV-Specific Cytotoxic T-Lymphocyte Responses in HIV-Exposed Healthcare Workers •
    Infection Control and Hospital Epidemiology, vol. 20, no. 6, pp. 428–430, 1999
  73. Aminooxypentane-RANTES, an Inhibitor of R5 Human Immunodeficiency Virus Type 1, Increases the Interferon gamma to Interleukin 10 Ratio without Impairing Cellular Proliferation
    AIDS Research and Human Retroviruses, vol. 15, no. 10, pp. 861–867, 1999
  74. Immune Restoration by Combination of a Cytostatic Drug (Hydroxyurea) and Anti-HIV Drugs (Didanosine and Indinavir)
    AIDS Research and Human Retroviruses, vol. 15, no. 7, pp. 619–624, 1999
  75. Alloimmunization for immune-based therapy and vaccine design against HIV/AIDS
    Immunology Today, vol. 20, no. 2, pp. 66–71, 1999
  76. Intractable pruritus in HIV infection: immunologic characterization
    Allergy, vol. 54, no. 3, pp. 266–272, 1999
  77. Immune responses to antigens of human endogenous retroviruses in patients with acute or stable multiple sclerosis
    Journal of Neuroimmunology, vol. 99, no. 2, pp. 173–182, 1999
  78. A role for mucosal immunity in resistance to HIV infection
    Immunology Letters, vol. 66, no. 1-3, pp. 21–25, 1999
  79. HIV-1-specific mucosal IgA in a cohort of HIV-1-resistant Kenyan sex workers
    AIDS, vol. 13, no. 1, pp. 23–29, 1999
  80. Aids, vol. 13, no. 4, pp. 465–471, 1999
  81. Thymus volume correlates with the progression of vertical HIV infection
    AIDS, vol. 13, no. 5, pp. F29–F34, 1999
  82. Differential Development of Type 1 and Type 2 Cytokines and β-Chemokines in the Ontogeny of Healthy Newborns
    Biology of the Neonate, vol. 75, no. 1, pp. 1–8, 1999
  83. Vaccine strategies for infectious diseases
    Expert Opinion on Investigational Drugs, vol. 8, no. 2, pp. 95–106, 1999
  84. Family Adaptation to Institutionalised Mentally Retarded Patients. A Preliminary Report on an Italian Population
    International Journal of Social Psychiatry, vol. 44, no. 2, pp. 135–146, 1998
  85. Aids, vol. 12, no. 8, pp. 895–904, 1998
  86. Aids, vol. 12, no. 18, pp. 2387–2396, 1998
  87. Cytokine dysregulation in invasive cervical carcinoma and other human neoplasias: time to consider the TH1/TH2 paradigm
    Journal of the National Cancer Institute, vol. 90, no. 4, pp. 261–263, 1998
  88. Glucocorticoid Resistance and the Immune Function in the Immunodeficiency Syndrome
    Annals of the New York Academy of Sciences, vol. 840, no. 1 NEUROIMMUNOMO, pp. 835–847, 1998
  89. ROLE OF CCR5 CHEMOKINE RECEPTOR GENE IN VERTICAL HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 TRANSMISSION AND DISEASE PROGRESSION
    The Pediatric Infectious Disease Journal, vol. 17, no. 9, pp. 847–849, 1998
  90. Cytokines production in chronic schizophrenia patients with or without paranoid behaviour
    Progress in Neuro-Psychopharmacology and Biological Psychiatry, vol. 22, no. 6, pp. 947–957, 1998
  91. Low CD4 counts rather than superantigenic-like effects account for differences in expressed T-cell receptor (TCR) repertoires between HIV-1 seropositive long-term non-progressors and individuals with progressive disease
    British Journal of Haematology, vol. 102, no. 5, pp. 1187–1196, 1998
  92. Increased levels of CD8+ and CD4 + 45RA + lymphocytes in schizophrenic patients
    Schizophrenia Research, vol. 31, no. 1, pp. 49–55, 1998
  93. Expression of CD38 on CD8 T cells predicts maintenance of high viraemia in HAART-treated HIV-1-infected children
    The Lancet, vol. 352, no. 9144, pp. 1905–1906, 1998
  94. Resistance to HIV infection: the genes are only part of the solution
    Trends in Microbiology, vol. 5, no. 1, pp. 2–4, 1997
  95. Vaccine strategies: Selective elicitation of cellular or humoral immunity?
    Trends in Biotechnology, vol. 15, no. 3, pp. 106–109, 1997
  96. A possible role for the cortisol/anticortisols imbalance in the progression of human immunodeficiency virus
    Psychoneuroendocrinology, vol. 22, pp. S27–S31, 1997
  97. HIV-specific mucosal and cellular immunity in HIV-seronegative partners of HIV-seropositive individuals
    Nature Medicine, vol. 3, no. 11, Article ID nm1197-1250, 7 pages, 1997
  98. Aids, vol. 11, no. 10, pp. F67–F71, 1997
  99. Cytokine production patterns in cervical intraepithelial neoplasia: association with human papillomavirus infection
    Journal of the National Cancer Institute, vol. 89, no. 3, pp. 245–250, 1997
  100. Glucocorticoids and the Immune Function in the Human Immunodeficiency Virus Infection: A Study in Hypercortisolemic and Cortisol-Resistant Patients
    Journal of Clinical Endocrinology & Metabolism, vol. 82, no. 10, pp. 3260–3263, 1997
  101. Glucocorticoids and interferon-alpha in the acquired immunodeficiency syndrome
    Journal of Clinical Endocrinology & Metabolism, vol. 81, no. 7, pp. 2601–2606, 1996
  102. The Tumor Enhancement Phenomenon: Reinterpretation From a Th1/Th2 Perspective
    Journal of the National Cancer Institute, vol. 88, no. 7, pp. 461–462, 1996
  103. Protective immunity against HIV infection: has nature done the experiment for us?
    Immunology Today, vol. 17, no. 1, pp. 21–24, 1996
  104. Soluble HIV suppressive factors: more than one Holy Grail?
    Immunology Today, vol. 17, no. 7, pp. 297–298, 1996
  105. HIV-1-specific immunity in persistently seronegative individuals at high risk for HIV infection
    Immunology Letters, vol. 51, no. 1-2, pp. 39–43, 1996
  106. Correlates of protection in HIV infection and the progression of HIV infection to AIDS
    Immunology Letters, vol. 51, no. 1-2, pp. 69–73, 1996
  107. Role of IL12 in HIV disease/AIDS
    Research in Immunology, vol. 146, no. 7-8, pp. 615–622, 1995
  108. Multiple defects of T helper cell function in newly diagnosed patients with Hodgkin's disease
    European Journal of Cancer, vol. 30, no. 10, pp. 1464–1470, 1994
  109. An immunoendocrinological hypothesis of HIV infection
    The Lancet, vol. 343, no. 8912, pp. 1552–1553, 1994
  110. The Th1–Th2 hypothesis of HIV infection: new insights
    Immunology Today, vol. 15, no. 12, pp. 575–581, 1994
  111. HIV-specific T-helper activity in seronegative health care workers exposed to contaminated blood
    JAMA: The Journal of the American Medical Association, vol. 271, no. 1, pp. 42–46, 1994
  112. Cytokines and HIV infection
    Seminars in Virology, vol. 5, no. 6, pp. 449–455, 1994
  113. Type 1/Type 2 Cytokine Modulation of T-Cell Programmed Cell Death as a Model for Human Immunodeficiency Virus Pathogenesis
    Proceedings of the National Academy of Sciences, vol. 91, no. 25, pp. 11811–11815, 1994
  114. VALUE OF IN VITRO CD4+ T HELPER CELL FUNCTION TEST FOR PREDICTING LONG-TERM LOSS OF HUMAN RENAL ALLOGRAFTS
    Transplantation, vol. 57, no. 3, p. 480, 1994
  115. Limiting dilution analysis of interleukin-2-producing T cells responsive to recall and alloantigens in human immunodeficiency virus-infected and uninfected individuals
    European Journal of Immunology, vol. 23, no. 2, pp. 412–417, 1993
  116. A TH1?TH2 switch is a critical step in the etiology of HIV infection
    Immunology Today, vol. 14, no. 3, pp. 107–111, 1993
  117. A Factor from CD8 Cells of Human Immunodeficiency Virus-Infected Patients Suppresses HLA Self-Restricted T Helper Cell Responses
    Proceedings of the National Academy of Sciences, vol. 89, no. 18, pp. 8424–8428, 1992
  118. Role of T-Cell Derived Cytokines in the Downregulation of Immune Responses in Parasitic and Retroviral Infection
    Immunological Reviews, vol. 127, no. 1, pp. 183–204, 1992
  119. Functional dichotomy of CD4+ T helper lymphocytes in asymptomatic human immunodeficiency virus infection
    European Journal of Immunology, vol. 21, no. 3, pp. 665–670, 1991
  120. Immunization with subunit human immunodeficiency virus vaccine generates stronger T helper cell immunity than natural infection
    European Journal of Immunology, vol. 21, no. 6, pp. 1345–1349, 1991
  121. Helper T-cell responses in children infected with human immunodeficiency virus type 1†
    The Journal of Pediatrics, vol. 118, no. 5, pp. 724–730, 1991
  122. Substance abuse and psychopathology
    Social Psychiatry and Psychiatric Epidemiology, vol. 24, no. 4, pp. 219–226, 1989
  123. Interleukin-2 production used to detect antigenic peptide recognition by T-helper lymphocytes from asymptomatic HIV-seropositive individuals
    Nature, vol. 339, no. 6223, Article ID 339383a0, 2 pages, 1989
  124. Involvement of families in group therapy of heroin addicts
    Drug and Alcohol Dependence, vol. 21, no. 3, pp. 213–216, 1988